Novartis acquires Avidity Biosciences! Novartis now has two FSHD therapies in development. "We look forward to continued progress under Novartis’s stewardship."
Read the announcement: www.fshdsociety.org/2025/10/27/novartis-acqu...

#Avidity #Novartis #FSHDResearch #FSHD